Mint Tower Capital Management’s Psyence Biomedical Warrant PBMWW Stock Holding History
Bought
Maintained
Sold
Other funds holding PBMWW
MI
Mint Tower Capital Management's PBMWW Position: Q3 2026 in Review
Mint Tower Capital Management held its Psyence Biomedical Warrant (PBMWW) position steady in Q3 2026 at 50,000 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #379.
Mint Tower Capital Management first reported a position in PBMWW in Q1 2024 and has held it in 11 quarters since. The position peaked at $4K in Q1 2024. 17 funds tracked by Wall St. Rank hold PBMWW as of Q3 2026.
- Mint Tower Capital Management held 50,000 shares of Psyence Biomedical Warrant worth $1K as of Q3 2026.
- Mint Tower Capital Management left its Psyence Biomedical Warrant share count unchanged in Q3 2026.
- Psyence Biomedical Warrant made up ﹤0.01% of Mint Tower Capital Management's portfolio in Q3 2026, its #379 holding.
- Mint Tower Capital Management first reported a position in Psyence Biomedical Warrant in Q1 2024 and has held it in 11 quarters since.
- Mint Tower Capital Management's Psyence Biomedical Warrant position peaked at $4K in Q1 2024.
- 17 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q3 2026.
Based on Mint Tower Capital Management's 13F filing for Q3 2026, filed 9 Nov 2026.